Imaging OEMs may find a major market in—did you say Cuba?

As trade and travel restrictions slowly loosen up with Cuba, U.S. suppliers of high-end medical equipment probably have a long wait before they have any chance at all to turn the “Pearl of the Antilles” into a hotspot of their market.

Some still say that day will never come. But Cuba Journal takes a look at the longer view—and sees in it the seeds of opportunity.

Cuba’s burgeoning medical tourism industry previously “generated annual revenues of $40 million despite the long-standing restrictions on trade and travel, a figure that is likely to increase as Cuba builds this sector, particularly if U.S. restrictions are removed,” an article in the journal stated June 6.

“In the longer term, this could translate into increased demand for various high-end medical devices and technologies, for which Cuban government officials have expressed a need.”

Read the piece:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.